Wegovy to reduce cardiovascular risks

The demand for new weight loss medications continues to skyrocket across the country. While initially approved for people with diabetes, Wegovy has also been approved for people with cardiovascular disease who are obese or overweight. A Metro Detroit heart expert says these drugs are now a promising option for many patients.